Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

61 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-23

Study Completion Date

2023-03-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Compare the effect of volume expansion by saline versus albumin on the correction of peripheral tissue hypoperfusion by measuring Index skin recoloration time (CRT) at H0 and H1

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Timing of Preload Responsiveness in Sepsis

NCT05627817

Septic Shock Fluid Responsiveness

UNKNOWN

Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?

NCT02116413

Septic Shock

COMPLETED

Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock

NCT04870892

Septic Shock

UNKNOWN

Early Albumin Resuscitation During Septic Shock

NCT00327704

Septic Shock

COMPLETED PHASE4

Evolution of Tissue Perfusion and Venous Congestion Markers in Fluid-Responsive Septic Shock Patients

NCT06958809

Septic Shock Fluid Resuscitation Congestion, Venous

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a transversal study allowing to compare the effect of volume expansion by saline versus albumin on the correction of peripheral tissue hypoperfusion

Design:

• A multicentric, open-label, transversal study

Sample size :

60 patients

Assessement:

Between the admission to intensive care and 48 hours after admission, the patient will be included after collection of the non-opposition form.

The patient will receive volume expansion either by 0.9% saline (500mL) or by 20% albumin (100mL) over 15 minutes.

Repeated clinical measurements will be performed at H0, H0.5 and H1 (respectively at 0, 30 and 60 minutes).

A blood sample will be taken just before the volume expansion and 4 hours after, at the same time as the samples usually taken as part of the treatment.

No interim analysis is planned. Analysis will be performed at the end of the study after data review and freezing of data base.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Septic Shock Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Effect of volume expansion by albumin on the correction of peripheral tissue hypoperfusion

Effect of volume expansion by albumin on the correction of peripheral tissue hypoperfusion by measuring the proportion of patients who normalized their cutaneous re-coloring time (CRT) measured at the index level, defined by a value \<3 seconds at H1. The clinical measurement method has been standardized in the participating departments and has been used for several years in clinical practice.

No interventions assigned to this group

Effect of volume expansion by saline on the correction of peripheral tissue hypoperfusion

Effect of volume expansion by saline on the correction of peripheral tissue hypoperfusion by measuring the proportion of patients who normalized their cutaneous re-coloring time (CRT) measured at the index level, defined by a value \<3 seconds at H1. The clinical measurement method has been standardized in the participating departments and has been used for several years in clinical practice.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age\> 18 years old
* Sepsis or
* Septic shock within 24 hours of admission to intensive care with a stable dose of norepinephrine for at least 2 hours to maintain MAP\> 65mmHg
* CRT index\> 3 seconds despite the initial resuscitation (administration of antibiotics, volume expansion by crystalloids of 20 mL / Kg, noradrenaline started) between the admission to intensive care and H48 from admission to intensive care
* Non-opposition of the patient collected by the doctor in charge of the patient between H0 and H6 after admission if the patient is vigilant, otherwise a procedure for collecting non-opposition from relatives will be carried out with collection of the non-opposition of the patient once he is able to give it.
* Affiliation to a social security regimen (excluding AME)

Exclusion Criteria

* Patient COVID-19 (+) with respiratory impairment
* Pregnant and lactating woman
* Patient under Guardianship / Curatorship
* Refusal to participate
* CRT not evaluable (dark or damaged skin)
* Moribund patient
* Estimated life expectancy less than 1 month
* Participation in another interventional research involving the human person or period of exclusion at the end of a previous research involving the human person

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No